全球麻风病市场 - 2028 年行业趋势和预测

市场分析与洞察：全球麻风病市场

预计全球麻风病市场将在 2021 年至 2028 年的预测期内实现市场增长。Data Bridge Market Research 分析称，在上述研究预测期内，市场复合年增长率为 3.50%。新兴市场和对研发的巨额投资是推动该市场增长的因素。

此外，治疗和诊断技术的进步以及麻风病患病率的上升也促进了市场的增长。政府意识计划的不断加强和世界各地麻风病患者人数的不断增加也促进了市场的增长。不断增加的新治疗选择为市场增长提供了机会。但是，医疗设施的可用性最低、缺乏认识和替代治疗的存在可能会阻碍全球麻风病市场的发展。

麻风病是一种由麻风分枝杆菌引起的严重传染病。麻风病会导致手臂、腿部和身体周围皮肤出现严重、毁容的皮肤溃疡和神经损伤。麻风分枝杆菌繁殖缓慢，疾病的潜伏期平均为 5 年。麻风病的症状在 1 年内出现，但有时长达 20 年或更长时间。

根据世界卫生组织 2018 年的数据，全球登记了 208,619 例新发麻风病病例。数据来自世界卫生组织 6 个地区的 159 个国家。登记的麻风病患病率不到每 10,000 人口 1 例。此外，根据美国国家罕见疾病组织的数据，约有 7,000 人因该病接受治疗，每年报告 150-200 例新发病例。麻风病病例最多的一些主要国家是印度、巴西、印度尼西亚、孟加拉国、缅甸、尼日利亚和莫桑比克。

This leprosy market provides details of market share, new developments and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Global Leprosy Market Scope and Market Size

The leprosy market is segmented on the basis of type, treatment, population, end-users and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

• On the basis of type, the leprosy market is segmented into borderline lepromatous leprosy, borderline tuberculoid leprosy, indeterminate leprosy, lepromatous leprosy, midborderline leprosy, tuberculoid leprosy and others.
• On the basis of treatment, the leprosy market is segmented into diagnosis, medication and others. Diagnosis segment further divided into skin smear test and others. Medication segment further divided into dapsone, rifampin, clofazimine, minocycline, oflaxacin, clarithromycin, prednisone, thalidomide and others.
• On the basis of population, the leprosy market is segmented into children and adults.
• On the basis of end-users, the leprosy market is segmented into hospitals, specialty clinics and others.
• On the basis of distribution channel, the leprosy market has also been segmented into direct tender, hospital pharmacy, retail pharmacy, online pharmacy and others. 

Leprosy Market Country Level Analysis

Leprosy market is analysed and market size information is provided by country, type, treatment, population, end-users and distribution channel as referenced above.

The countries covered in the leprosy market report are U.S., Canada, Mexico in North America, Brazil, Argentina, Peru, Rest of South America, as part of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa, as a part of Middle East and Africa.

从地域上看，北美占据最大的市场份额，因为那里的医疗费用很高，而且针对治疗的临床研究也越来越多。由于麻风病发病率不断上升，对成本效益高的治疗药物的需求不断增加，预计亚太地区将在未来几年占据麻风病市场最大的市场份额。

报告的国家部分还提供了影响单个市场因素和国内市场法规变化，这些变化影响了市场的当前和未来趋势。新销售、替代销售、国家人口统计、疾病流行病学和进出口关税等数据点是用于预测单个国家市场情景的一些主要指标。此外，在对国家数据进行预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、销售渠道的影响。

患者流行病学分析

麻风病市场还为您提供详细的市场分析，包括患者分析、预后和治疗。患病率、发病率、死亡率、依从率是报告中提供的一些数据变量。分析流行病学对市场增长的直接或间接影响，以创建更稳健、更全面的多元统计模型，用于预测增长期的市场。

竞争格局和麻风病市场份额分析

麻风病市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、公司优势和劣势、产品发布、临床试验渠道、产品批准、专利、产品宽度和广度、应用优势、技术生命线曲线。以上提供的数据点仅与公司对麻风病市场的关注有关。

麻风病市场的主要参与者包括 Leo Pharma A/s、GlaxoSmithKline plc、Pfizer Inc.、Mylan NV、Macleods Pharmaceuticals、Cadila Pharmaceuticals、Johnson & Johnson Services, Inc. Teva Pharmaceutical Industries Ltd.、Bayer AG、Galderma SA、Sun Pharmaceutical Industries Ltd.、Perrigo Pharmaceutical plc.、Novartis AG、AstraZeneca plc、Sanofi 以及其他国内和全球参与者。DBMR 分析师了解竞争优势并为每个竞争对手分别提供竞争分析。

SKU-59630